The Board Winteam Pharmaceutical Group Limited announced that each of Mr. Wu Xian and Mr. Lu Jun has been appointed as an Executive Director, each of Mr. She Lulin, Mr. Liu Cunzhou and Mr. Zhao Dongji has been appointed as a non-executive Director and each of Mr. Zhou Bajun, Mr. Xie Rong and Mr. Fang Shuting has been appointed as an independent non-executive Director, in each case with effect after the despatch of the Composite Document (the "Appointed Directors"). Mr. Wu Xian, was previously head of the planning and development department of Harbin Pharmaceutical Group Co. Ltd., deputy plant manager of Harbin Pharmaceutical Group Co.

Ltd. Mr. Lu Jun, was previously the general manager of each of China National Pharmaceutical Group Shanghai Likang Medicine Co. Ltd., Shanghai Guoda Pharmacy Chain Store Co. Ltd. and Sinopharm Holding Guoda Drug Store Co.

Ltd. Mr. She Lulin has been the vice-chairman, general manager and deputy secretary of Party Committee of CNPGC from October 2009 to present. Mr. She has been the chairman and legal representative of Sinopharm Industrial Investment Co. Ltd. from July 2008 to present.

Mr. Liu Cunzhou is currently the chief expert of CNPGC. Mr. Zhao Dongji has served as chief investment officer and manager of Investment Management Department of China National Corp. of Traditional & Herbal Medicine since 2011.

The Board also announced that each of Mr. Xu Tiefeng, Mr. Situ Min, Mr. Du Richeng, Mr. Lo Wing Yat, Mr. Pang Fu Keung, Mr. Wang Bo and Mr. Zhang Jianhui tendered resignation as a Director, in each case with effect from the first closing Date. Each has confirmed that resigned was as a result of the acquisition and the offer and has no disagreement with the Board, and there is no matter in relation to his resignation that needs to be brought to the attention of the shareholders.